ENTITY
Shanghai RAAS Blood Products C

Shanghai RAAS Blood Products C (002252 CH)

11
Analysis
Health CareChina
Shanghai RAAS Blood Products Co., Ltd. produces blood products. The Company develops and manufactures human albumin, human immunoglobulin, coagulation factors, tetanus human immunoglobulin, and other products. Shanghai RAAS Blood Products markets its products throughout China.
more
25 Jan 2024 08:55

Haier Group to Buy $1.8B Stake in Shanghai RAAS from Grifols – A New Chapter Begins

We analyzed the key points/logic behind Haier's decision to acquire Shanghai RAAS from Grifols. Despite potential risks, it is still a wise move...

Logo
491 Views
Share
bullishGrifols SA
08 Jul 2024 16:47

(Desperate) Takeover Bid in the Making

Grifols' founding families and Brookfield ask the Board for the necessary information to evaluate an offer for 100% of Grifols SA (GRF SM). The...

Share
bullishGrifols SA
01 Jul 2024 00:17

Another Debt Downgrade

​Moody's downgrades Grifols' rating due to high leverage and opaque governance. For risk-tolerant investors, the current low share price could...

Share
24 Apr 2024 08:55

Tiantan (600161CH) To Acquire Weiguang (002880CH)- New King Rises in China's Blood Products Industry

The change of Weiguang's actual controller will bring about a series of restructuring.As SOE reform enters new stage, investors will have good...

Logo
306 Views
Share
17 Dec 2023 10:15

Northbound Flows (Dec 15th): China Yangtze Power, Mindray, BYD, Wuliangye

We analyzed northbound Shanghai/Shenzhen connect flows in the past week and highlight flows for China Yangtze Power, Mindray, BYD, Wuliangye.

Logo
412 Views
Share
x